英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
valebant查看　valebant　在百度字典中的解释百度英翻中〔查看〕
valebant查看　valebant　在Google字典中的解释Google英翻中〔查看〕
valebant查看　valebant　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of . . .
    When the VEGF-A-targeting monoclonal antibody bevacizumab (Avastin®) entered clinical practice more than 15 years ago, it was one of the first targeted therapies and the first approved angiogenesis inhibitor pericytes, immune cells and fibroblasts, as well as the extracellular matrix Cancer cells influence their microenvironment by
  • Avastin (bevacizumab): Side effects, uses, alternatives, and more
    It’s a monoclonal antibody, which is a type of drug made from immune system cells Avastin is FDA-approved to treat the following cancers in adults in certain situations: recurrent* glioblastoma
  • Immune Effects of Bevacizumab: Killing Two Birds with One Stone
    Blockade of VEGF led to increase in the maturation of DCs and to the inhibition of tumour infiltration with immune-regulatory cells like T-regs and myeloid-derived suppressor cells (MDSC) These changes in the immune cells population in the tumour microenvironment were correlated with changes in the serum levels of cytokines like IL-6 and IL-1β
  • Immunosuppressive effects of vascular endothelial growth factor
    Since 2004, bevacizumab (Avastin), a humanized anti-VEGFA monoclonal antibody, has been approved for the treatment of non-small cell lung, breast, kidney and ovarian cancer in combination with standard chemotherapy VEGF has been demonstrated to be important in the clinic as a therapeutic target in the anti-angiogenic approach to cancer therapy
  • Bevacizumab (Avastin®) - Perelman School of Medicine at the University . . .
    About Bevacizumab (Avastin®) Monoclonal antibodies are created in a lab to attach to the targets found on specific types of cancer cells The antibody “calls” the immune system to attack the cell it is attached to, resulting in the immune system killing the cell These antibodies can work
  • Tumor cell response to bevacizumab single agent therapy in vitro
    Where indicated, 50 ng ml recombinant human VEGFA (Miltenyi Biotec, Germany) and 250 μg ml bevacizumab (Avastin, was provided by Roche, Switzerland), was added tumor stroma, immune cells as well as the tumor cells Conclusions Bevacizumab was the first approved therapeutic agent targeting blood vessels of tumors, which has shown efficacy
  • Bevacizumab improves tumor infiltration of mature dendritic cells and . . .
    The changes in infiltrating immune cells induced by bevacizumab should be further evaluated in clinical studies as predictive dynamic biomarkers of treatment efficacy and patient selection for
  • Bevacizumab (Avastin®) in cancer treatment A review of 15 years of . . .
    Bevacizumab(Avastin®)incancertreatment:Areviewof15yearsofclinical experienceandfutureoutlook JosepGarciaa, pericytes, immune cells and fibroblasts, as well as the extracellular matrix Cancer cells influence their microenvironment by releasing extracellular signals, to induce tumor angiogenesis, stimulate cancer
  • Avastin: Side Effects, Cost, How It’s Given, Uses, and More - Healthline
    Avastin works* with your immune system to block a specific protein called vascular endothelial growth factor (VEGF) VEGF is found naturally in many cells throughout your body But VEGF is also
  • Avastin Questions and Answers - WebMD
    A: Avastin is a monoclonal antibody, a synthetic version of antibodies that our bodies produce and which fight foreign substances Avastin binds to a molecule called vascular endothelial growth





中文字典-英文字典  2005-2009